Total Payments
$205,530
2024 Payments
$0
Companies
31
Transactions
580
Medicare Patients
750
Medicare Billing
$262,884
Payment Breakdown by Category
Other$140,056 (68.1%)
Travel$41,609 (20.2%)
Food & Beverage$13,233 (6.4%)
Consulting$9,232 (4.5%)
Research$1,393 (0.7%)
Education$6.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,600 | 81 | 67.4% |
| Travel and Lodging | $41,609 | 124 | 20.2% |
| Food and Beverage | $13,233 | 365 | 6.4% |
| Consulting Fee | $9,232 | 4 | 4.5% |
| Unspecified | $1,393 | 2 | 0.7% |
| Honoraria | $1,200 | 1 | 0.6% |
| Entertainment | $255.86 | 2 | 0.1% |
| Education | $6.80 | 1 | 0.0% |
Payments by Type
General
$204,137
578 transactions
Research
$1,393
1 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $103,489 | 208 | $0 (2020) |
| AKEBIA THERAPEUTICS INC | $48,946 | 82 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $17,422 | 37 | $0 (2018) |
| AbbVie, Inc. | $11,529 | 45 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $10,368 | 26 | $0 (2019) |
| Vifor Pharma, Inc. | $5,652 | 18 | $0 (2022) |
| La Jolla Pharmaceutical Company | $1,646 | 10 | $0 (2019) |
| Otsuka Pharmaceutical Co., Ltd. | $1,393 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,006 | 4 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $805.12 | 44 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 1 | ExThera Medical Corporation |
| 2022 | $5,582 | 22 | AKEBIA THERAPEUTICS INC ($3,973) |
| 2021 | $22,194 | 49 | AKEBIA THERAPEUTICS INC ($16,673) |
| 2020 | $7,116 | 39 | Relypsa, Inc. ($4,358) |
| 2019 | $54,017 | 141 | Relypsa, Inc. ($26,952) |
| 2018 | $59,024 | 151 | Relypsa, Inc. ($37,611) |
| 2017 | $57,596 | 177 | Relypsa, Inc. ($34,568) |
All Payment Transactions
580 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | ExThera Medical Corporation | — | — | — | $0.00 | Ownership |
| 10/28/2022 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | Cash or cash equivalent | $35.94 | General |
| Category: Nephrology | ||||||
| 09/28/2022 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | Cash or cash equivalent | $38.83 | General |
| Category: Nephrology | ||||||
| 08/17/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,475.00 | General |
| Category: Nephrology | ||||||
| 07/27/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Travel and Lodging | Cash or cash equivalent | $1,174.43 | General |
| Category: Nephrology | ||||||
| 07/27/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | Cash or cash equivalent | $121.87 | General |
| Category: Nephrology | ||||||
| 06/29/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,170.00 | General |
| Category: Nephrology | ||||||
| 06/23/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/21/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Immunosuppresant | ||||||
| 06/02/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/18/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/28/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: Nephrology | ||||||
| 04/28/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Nephrology | ||||||
| 04/27/2022 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $26.97 | General |
| 04/26/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Autoimmune | ||||||
| 04/13/2022 | Vifor Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| 03/31/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/22/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: NEPHROLOGY | ||||||
| 03/03/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/23/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Hyperkalemia | ||||||
| 02/17/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: Hyperkalemia | ||||||
| 01/24/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Nephrology | ||||||
| 12/09/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEPHROLOGY | ||||||
| 11/23/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Cardio-renal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE NDD-CKD PRO2TECT-CORRECTION | Otsuka Pharmaceutical Co., Ltd. | $1,393 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 154 | 456 | $147,007 | $59,066 |
| 2022 | 4 | 176 | 499 | $158,488 | $61,931 |
| 2021 | 6 | 211 | 522 | $165,793 | $79,337 |
| 2020 | 5 | 209 | 511 | $137,909 | $62,549 |
Total Patients
750
Total Services
1,988
Medicare Billing
$262,884
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 12 | 102 | $63,420 | $30,361 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 323 | $75,905 | $25,528 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,928 | $2,002 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $2,754 | $1,175 | 42.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 12 | 104 | $63,440 | $31,952 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 351 | $82,485 | $25,566 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,688 | $2,771 | 41.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 19 | 25 | $5,875 | $1,642 | 28.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 299 | $70,265 | $31,736 | 45.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 15 | 95 | $57,950 | $29,630 | 51.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 72 | $16,920 | $7,944 | 46.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 31 | $9,765 | $4,892 | 50.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 11 | 13 | $6,669 | $3,363 | 50.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,224 | $1,774 | 42.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 313 | $63,187 | $28,115 | 44.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 21 | 96 | $51,176 | $23,705 | 46.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 34 | 70 | $14,524 | $6,487 | 44.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,147 | $2,307 | 44.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 15 | $3,875 | $1,936 | 50.0% |
About Dr. Ajit Sawhney, M.D
Dr. Ajit Sawhney, M.D is a Nephrology healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114014438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajit Sawhney, M.D has received a total of $205,530 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 580 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,600).
As a Medicare-enrolled provider, Sawhney has provided services to 750 Medicare beneficiaries, totaling 1,988 services with total Medicare billing of $262,884. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Fountain Valley, CA
- Active Since 10/06/2006
- Last Updated 01/16/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114014438
Products in Payments
- Veltassa (Drug) $107,813
- Auryxia (Drug) $38,068
- AURYXIA (Drug) $28,300
- ACTHAR (Biological) $10,475
- Mavyret (Drug) $4,464
- Viekira (Drug) $3,755
- GIAPREZA (Drug) $1,646
- Kerendia (Drug) $1,006
- Rayaldee (Drug) $743.98
- Velphoro (Drug) $370.91
- Not Product Related (Medical Supply) $272.88
- NephroCheck Test (Device) $255.86
- JYNARQUE (Drug) $252.12
- Parsabiv (Biological) $241.69
- SAMSCA (Drug) $211.05
- KRYSTEXXA (Biological) $152.51
- Envarsus XR (Drug) $149.48
- Envarsus (Drug) $145.96
- ZEPATIER (Drug) $145.04
- Parsabiv (Drug) $131.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Fountain Valley
Rallabhandi Sankaram, M.d, M.D
Nephrology — Payments: $6,738
Nephrology $6,738
Thanh Cao, D.o, D.O
Nephrology — Payments: $6,424
Nephrology $6,424
Dr. Sajeet Sawhney, M.d, M.D
Nephrology — Payments: $6,179
Nephrology $6,179
Alan Cantillep, Md, MD
Nephrology — Payments: $4,174
Nephrology $4,174
Dr. Zavier Ahmed, M.d, M.D
Nephrology — Payments: $1,799
Nephrology $1,799
Dr. Sandeep Dang, M.d, M.D
Nephrology — Payments: $1,606
Nephrology $1,606